GEODE CAPITAL MANAGEMENT, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$430,190
+127552.8%
3,449,805
+5.4%
0.00%
Q4 2022$337
-99.9%
3,272,616
-3.2%
0.00%
Q3 2022$514,000
-82.7%
3,379,691
+0.1%
0.00%
Q2 2022$2,970,000
-25.8%
3,375,473
+4.6%
0.00%
Q1 2022$4,002,000
-33.2%
3,227,765
+5.0%
0.00%
-100.0%
Q4 2021$5,991,000
-29.0%
3,072,661
-0.2%
0.00%0.0%
Q3 2021$8,435,000
-11.1%
3,078,554
+2.2%
0.00%0.0%
Q2 2021$9,491,000
+329.8%
3,013,208
+190.6%
0.00%
Q1 2021$2,208,000
+295.7%
1,036,823
+260.0%
0.00%
Q4 2020$558,000
+218.9%
288,039
+14.5%
0.00%
Q3 2020$175,000
+32.6%
251,6560.0%0.00%
Q2 2020$132,000
+20.0%
251,6560.0%0.00%
Q1 2020$110,000
-68.0%
251,656
-49.6%
0.00%
Q4 2019$344,000
+91.1%
499,186
+195.6%
0.00%
Q3 2019$180,000
+47.5%
168,8520.0%0.00%
Q2 2019$122,000
-38.1%
168,852
+9.3%
0.00%
Q1 2019$197,000
-57.4%
154,457
-50.0%
0.00%
Q4 2018$462,000
+133.3%
308,914
+125.9%
0.00%
Q3 2018$198,000
+5.9%
136,7360.0%0.00%
Q2 2018$187,000
+592.6%
136,736
+354.3%
0.00%
Q1 2018$27,000
-18.2%
30,0970.0%0.00%
Q4 2017$33,000
-31.2%
30,0970.0%0.00%
Q3 2017$48,000
-14.3%
30,0970.0%0.00%
Q2 2017$56,000
-3.4%
30,0970.0%0.00%
Q1 2017$58,000
-48.2%
30,0970.0%0.00%
Q4 2016$112,000
-10.4%
30,0970.0%0.00%
Q3 2016$125,00030,0970.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders